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Abstract
The impact of chromosome architecture in the formation of chromosome aberrations is a recent finding 
of interphase directed molecular cytogenetic studies. There evidence was provided that disease specific 
chromosomal translocations could be due to tissue specific genomic organization. In a recent small pilot study 
using three-dimensional interphase fluorescence in situ hybridization, we showed that there might be a specific 
chromosome positioning in myeloid bone marrow cells, i.e. a co-localization of chromosomes 8 and 21. Here 
we could substantiate this finding in overall 21 studied cases with acute myeloid leukemia (AML) that there is 
even a co-localization of the genes AML1 and ETO. This finding led to the suggestion that a specific interphase 
architecture of myeloid bone marrow cells might promote the typical t(8;21)(q22;q22) leading to AML-M2. 
Introduction 
Analysis of the location of chromosomes and genes 
in a number of cell types and tissues has revealed that 
“genomic elements” (i.e. here chromosomes) occupy 
preferential positions within the nucleus which are called 
‘chromosome territories’ [1-3]. Chromosome size and 
density of the genes within a chromosome are discussed 
to have an impact on the nuclear position of chromosomes 
[4]. Furthermore, non-random positioning in interphase 
nuclei is known to be of importance for genomic stability 
and formation of chromosome aberrations. Tissue 
specificity of chromosomal translocations could be due to 
tissue specific genome organization [5-6], and a positive 
correlation between spatial proximity of chromosomes/
genes in interphase nuclei and translocation frequencies 
was shown [5-10]. Three-dimensional (3D) fluorescence 
in situ hybridization (FISH) analysis became a major tool 
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for studying this higher order chromatin organization in 
the cell nucleus [4; 11-15].
Trisomy 8, the most frequently occurring numerical 
chromosome aberration in acute myeloid leukemia 
(AML) and myelodysplastic syndromes (MDS), can 
be associated with other karyotypic abnormalities, or 
occur as sole abnormality. Trisomy 8 is also a marker for 
progression in chronic myelogeneous leukemia (CML). 
A variety of hematological diseases are connected with 
trisomy 8, indicating a non-specific role in leukemia 
pathogenesis. The prognostic impact of trisomy 8 as the 
sole change in AML and MDS is discussed controversial 
in the literature [16-19]. However, another frequent 
cytogenetic abnormality involving chromosome 8, 
the reciprocal translocation t(8;21) usually correlates 
with AML-M2 and indicate a good prognosis [20]. The 
AML1-ETO (also RUNX1/MTG8) fusion oncoprotein, 
generated by the t(8;21) chromosomal translocation, is 
causally involved in nearly 15% of AML cases. AML1/
ETO consists of the N-terminal DNA-binding domain 
of AML1, a transcription factor essential for definitive 
hematopoiesis, and almost all of ETO, a protein thought 
to function as a co-repressor for a variety of transcription 
factors [21]. 
In a previous study the (relative) 3D position of 
chromosomes 8 and 21 to each other was studied in 
interphase nuclei of AML cases with trisomy 8 [11]. In 
the present study we enlarged the number of cases and 
analyzed relative position of not only chromosomes 8 and 
21 [11] but also the genes suggested to be involved ETO 
and AML1. Bone marrow (BM) of AML, MDS and CML 
cases with trisomy 8 were studied in comparison with BM 
of six AML-M2 cases in remission, BM of two control 
cases with autoimmune thrombocytopenia and PBL of 
four healthy donors, each with normal karyotype. The well 
established approach of interphase chromosome-specific 
multicolor banding (ICS-MCB) [15], partial chromosome 
paining (PCP) probes and LSI AML1/ETO Dual Color, 
Dual Fusion Translocation Probe (Vysis) combined with 
suspension FISH (S-FISH) [14] were chosen for this 
study. 
Material and Methods 
The studied patients are listed in Table 1.
Multicolor banding (MCB) probe sets for 
chromosomes 8 and 21 were applied in suspension-
FISH (S-FISH) as previously reported [11]. Images of 
Table 1. Overview of the 21 cases with and without trisomy 8, studied material and karyotypes; AML-M2 cases had originally a t(8;21). 
Cases with asterisks were previously published in Manvelyan et al. [11]. Abbreviation: mMCB = multitude multicolor banding [25].
Case 
number
Age
(y)
Material Karyotype after GTG 
or mMCB
1* 30 bone marrow (secondary AML from MDS) 47,XY,+8[21]/46,XY[4]
2* 83 bone marrow (secondary AML from MDS) 47,XY,+8[24]/46,XY[3]
3* 57 bone marrow (secondary AML from MDS; in blast crisis) 47,XY,+8[13]/46,XY[1]
4 86 bone marrow (MDS) 47,XY,+8[13]
5 47 bone marrow (MDS) 47,XY,+8[18]
6 69 bone marrow (MDS RA) 47,XY,+8,14pst+[12]
7 72 bone marrow (secondary AML from MDS) 47,XX,+8[9]/46,XY[5]
8 53 bone marrow (secondary AML from MDS) 47,XX,+8[8]/46,XY[8]
9 60 bone marrow (CML) 47,XY,+8[12]
10 64 bone marrow (autoimmune thrombocytopenia) 46,XY
11 21 bone marrow (autoimmune thrombocytopenia) 46,XY
12* 25 stimulated peripheral blood-lymphocytes (healthy) 46,XX[20]
13 25 stimulated peripheral blood-lymphocytes (healthy) 46,XX[20]
14 35 stimulated peripheral blood-lymphocytes (healthy) 46,XY[20]
15 33 stimulated peripheral blood-lymphocytes (healthy) 46,XX[20]
16 44 bone marrow (AML-M2 in remission) 46,XX
17 36 bone marrow (AML-M2 in remission) 46,XY
18 22 bone marrow (AML-M2 in remission) 46,XY
19 21 bone marrow (AML-M2 in remission) 46,XX
20 49 bone marrow (AML-M2 in remission) 46,XY
21 50 bone marrow (AML-M2 in remission) 46,XX
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3D-preserved interphase nuclei were captured on a Zeiss 
Axioplan microscope and analyzed by Cell-P (Olympus) 
software. In the same way, the LSI AML1/ETO Dual 
Color - Dual Fusion Translocation Probe (Vysis) was used 
and analyzed.
For the 3D-evaluation, position and distance of 
homologous chromosomes/ signals were determined. 
The interphase nucleus was divided into two spheres, i.e. 
periphery (P) and center (C); 50% of the nucleus radius 
was defined as ‘center’. Thus, analyzed chromosomes 
could be allocated either as C or P. The relative positions 
of the studied chromosomes to each other were recorded 
as ‘close together’ (t), ‘near by each other’ (n) or ‘on the 
opposite sides of the nucleus’ (o) for two homologue 
chromosomes. In cells with three chromosomes 8 this 
nomenclature was combined to ‘o-n’, ‘o-t’ or ‘t-n’ - for 
examples see [11].  
Statistical analysis was performed using Student’s 
t-test, One Way ANOVA (Analysis of Variance) and 
Holm-Sidak method. Statistical significance was defined 
as p<0.05. 
Results and Discussion 
In the present study we found that chromosome 8 
is predominantly positioned in the periphery (P) of 
interphase nuclei. The position of chromosome 8 in BM 
cells and peripheral blood-lymphocytes is in concordance 
with the data of our previous study determined in haploid 
human sperm [4]. The additional chromosome in trisomy 
8 was located in periphery rather than central. If this is 
general behavior of additional chromosomes present 
cannot be answered yet. According to the present study, 
homologue chromosomes 8 are located primarily in close 
proximity, i.e. close together (t). 
Observed position of chromosome 21 was in 
concordance with the literature [22-23]. In all here 
studied diploid cases, homologue chromosomes 21 
behaved as postulated for acrocentrics and co-localized 
to each other in a more central position. Previously, it was 
postulated [22-23] that their co-localization is caused by 
the nucleolar organizer regions on their short arms, and 
that the nucleolus is located in the inner nuclear space. 
Correlation between spatial proximity of chromosomes/
genes in interphase nuclei and translocation frequencies 
was shown before and chromosomes located in proximity 
underwent translocation events more frequently than 
distantly located ones [6; 10; 12]. To test this hypothesis 
for the reciprocal translocation t(8;21) usually correlated 
with AML, here a 3D analysis for co-localization of 
chromosomes 8 and 21 was done (Table 2). 
As reported [11] a random co-localization was 
compared to the observed co-localization rate of one 
chromosome 8 and 21, each. This was done based on 
Table 2. Summary of the results obtained after S-FISH using locus 
specific probes for t(8;21) AML1/ETO Dual Color, Dual Fusion 
Translocation Probe (Vysis) or ICS-MCB. In gray are those cases in 
which a co-localization of AML1 and ETO genes and co-localization 
of one chromosome 8 and one 21 was more frequently observed than 
expected in a random distribution. 
Observed co-localization
AML1-ETO 
(M±m)%
ICS-MCB 
(M±m)%
AML, MDS (trisomy 8) 
1 44.6±6.4 –
2 36.7±6.3 –
3 50.0±6.9 –
4 28.8±6.3 38.0±6.9
5 40.0±6.2 47.8±7.4
6 35.9±6.0 65.2±5.9
7 36.5±6.7 66.7±5.8
8 46.4±6.7 55.2±6.6
AML, MDS (disomy 8)
2 18.2±8.4 –
3 25.0±9.9 –
7 – 58.3±14.9
8 21.4±11.4 20.0±13.3
СML (trisomy 8)
9 15.4±5.1 25.0±5.8
Control (BM)
10 8.0±3.9 7.5±4.2
11 4.0±2.8 6.0±3.4
Control (PBL)
12 16.1±4.7 –
13 16.1±4.7 –
14 16.0±4.4 19.4±5.1
15 – 15.4±5.1
Remission
16 29.2±6.6 34.6±6.7
17 30.4±6.2 39.1±7.6
18 10.4±4.5 20.0±2.7
19 10.9±4.6 18.3±5.0
20 13.5±4.8 22.0±5.9
21 8.8±4.9 22.5±6.7
BM = bone marrow; 
M = Means; 
m = Standard error; 
PBL = peripheral blood lymphocytes; 
– = not analyzed.
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Figure 1. ICS-MCB results after FISH using locus-specific probes 
for ETO and AML1 in nuclei with trisomy 8: (A) Nucleus without 
any co-localization of any of the five specific signals obtained; (B) 
Nucleus with co-localization of one ETO- and one AML1-specific 
signal (arrowhead).
interphase ICS-MCB applied in S-FISH and using 
locus-specific probes for the AML1/ETO translocation 
(Figure 1). A significant enhanced co-localization rate 
was found in all studied trisomy 8 AML-cases (Table 2), 
with exception of trisomic cells of case 4 and disomic 
cells of cases 3 and 8, compared to controls. In all other 
cases (normal controls, CML and AML-M2 in remission) 
practically no co-localization of one chromosome 8 and 
21 was observed, with exception of case 17. 
Generally, in trisomy 8 cells there was a significant 
co-localization of the locus-specific probes AML1 and 
ETO in 7 out of 8 cases, while by ICS-MCB and looking 
at whole chromosomes 8 and 21 such a correlation was 
only observable in 2 out of five cases. Even in two out 
of four of these cases, the cells with disomy 8 showed 
a significant co-localization of one chromosome 8 and 
21 including AML1 and ETO. Neither in the one CML-
case with trisomy 8 nor in stimulated peripheral blood 
T-lymphocytes was this co-localization found; also not 
in BM of patients with autoimmune thrombocytopenia. 
Finally, in one out of the six cases with AML2 in 
remission a co-localization of AML1 and ETO could 
be proven. This inconsistency of chromosome 8 and 21 
co-localization might also point towards new entities of 
AML2 distinguishable only by 3D-FISH analysis. Also, 
in cases with trisomy 8 and AML1-ETO fusion, t(8;21)
(q22;q22) might have to be considered as secondary 
rather than primary event. Still, at present it is not clear 
if a co-localization of chromosomes 8 and 21 promotes a 
translocation between the two chromosomes in AML-M2 
or even in AML-cases with trisomy 8. 
Overall, further studies in AML are necessary for 
delineation of interphase architecture in this cell type as 
in cancer in general. At present, as supported by recent 
comparable findings in thyroid cancer, a clinical impact 
of 3D-chromosome positioning on malignancies becomes 
more and more likely [24].
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